トリプトリド
“Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease”. PNAS 104 (11): 4389–4394. doi:10.1073/pnas.0700499104. PMC 1838612. PMID 17360534. http://www.pnas.org/content/104/11/4389.abstract 2012年10月18日閲覧。.
1 2 3 Chugh, Rohit (2012). “A Preclinical Evaluation of Minnelide as a Therapeutic Agent Against Pancreatic Cancer”. Science Translational Medicine 4 (156): 156ra139. doi:10.1126/scitranslmed.3004334. PMC 3656604. PMID 23076356. http://stm.sciencemag.org/content/4/156/156ra139.abstract 2012年10月18日閲覧。.
↑ Liu Q. (2011). “Triptolide and its expanding multiple pharmacological functions”. International Immunopharmacology 11 (3): 377–383.
doi:10.1016/j.intimp.2011.01.012. PMID 21255694.
↑ “Study of Minnelide in Patients With Advanced GI Tumors”. 2016年10月6日閲覧。
↑ S. J. Leuenroth, D. Okuhara, J. D. Shotwell, G. S. Markowitz, Z. Yu, S. Somlo, C. M. Crews, Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease. Proc Natl Acad Sci U S A 2007, 104, 4389-4394;
↑ R. Soundararajan, R. Sayat, G. S. Robertson, P. A. Marignani,Triptolide: An inhibitor of a disintegrin and metalloproteinase 10 (ADAM10) in cancer cells. Cancer Biol Ther 2009, 8, 2054-2062;
↑ T. W. Corson, H. Cavga, N. Aberle, C. M. Crews, Triptolide directly inhibits dCTP pyrophosphatase.